Ultimovacs ASA

OSTO:ULTIo (Norway)   Ordinary Shares
kr 2.19 (+8.44%) Dec 4
At Loss
P/B:
0.38
Market Cap:
kr 73.11M ($ 6.61M)
Enterprise V:
kr -55.33M ($ -5.00M)
Volume:
15.21K
Avg Vol (2M):
9.43K
Trade In:
Volume:
15.21K
At Loss
Avg Vol (2M):
9.43K

Business Description

Description
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.
Name Current Vs Industry Vs History
Cash-To-Debt 51.31
Equity-to-Asset 0.89
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 62.27
9-Day RSI 58.83
14-Day RSI 57.17
6-1 Month Momentum % -77.31
12-1 Month Momentum % -98.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.36
Quick Ratio 11.36
Cash Ratio 10.63
Days Payable 1064.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4
Shareholder Yield % 2.27

Financials (Next Earnings Date:2025-02-13)

OSTO:ULTIo's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ultimovacs ASA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr)
EPS (TTM) (kr) -4.4
Beta 0
Volatility % 127.35
14-Day RSI 57.17
14-Day ATR (kr) 0.092384
20-Day SMA (kr) 2.03075
12-1 Month Momentum % -98.19
52-Week Range (kr) 1.684 - 157
Shares Outstanding (Mil) 34.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ultimovacs ASA Filings

Filing Date Document Date Form
No Filing Data

Ultimovacs ASA Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Ultimovacs ASA Frequently Asked Questions

What is Ultimovacs ASA(OSTO:ULTIo)'s stock price today?
The current price of OSTO:ULTIo is kr2.19. The 52 week high of OSTO:ULTIo is kr157.00 and 52 week low is kr1.68.
When is next earnings date of Ultimovacs ASA(OSTO:ULTIo)?
The next earnings date of Ultimovacs ASA(OSTO:ULTIo) is 2025-02-13.
Does Ultimovacs ASA(OSTO:ULTIo) pay dividends? If so, how much?
Ultimovacs ASA(OSTO:ULTIo) does not pay dividend.

Press Release

Subject Date
No Press Release